Biotage AB
Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, parallel peptide purification, and work-up products; flash systems and accessories, and normal and reversed phase cartridges; sample preparation produ… Read more
Market Cap & Net Worth: Biotage AB (BIOT)
Biotage AB (ST:BIOT) has a market capitalization of $1.02 Billion (Skr11.46 Billion) as of March 18, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #8287 globally and #52 in its home market, demonstrating a 0.28% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Biotage AB's stock price Skr143.20 by its total outstanding shares 80051904 (80.05 Million).
Biotage AB Market Cap History: 2015 to 2025
Biotage AB's market capitalization history from 2015 to 2025. Data shows growth from $154.48 Million to $1.02 Billion (24.88% CAGR).
Biotage AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Biotage AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.56x
Biotage AB's market cap is 0.56 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
4.04x
Biotage AB's market cap is 4.04 times its annual earnings
841.57x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $154.48 Million | $610.53 Million | $73.25 Million | 0.25x | 2.11x |
| 2016 | $299.28 Million | $667.91 Million | $92.80 Million | 0.45x | 3.23x |
| 2017 | $561.19 Million | $748.15 Million | $138.75 Million | 0.75x | 4.04x |
| 2018 | $739.66 Million | $910.90 Million | $167.63 Million | 0.81x | 4.41x |
| 2019 | $851.33 Million | $1.10 Billion | $186.82 Million | 0.77x | 4.56x |
| 2020 | $954.31 Million | $1.09 Billion | $175.00 Million | 0.87x | 5.45x |
| 2021 | $1.81 Billion | $1.23 Billion | $205.00 Million | 1.47x | 8.85x |
| 2022 | $1.29 Billion | $1.57 Billion | $268.00 Million | 0.83x | 4.83x |
| 2023 | $944.81 Million | $1.86 Billion | $246.00 Million | 0.51x | 3.84x |
| 2024 | $1.15 Billion | $2.06 Billion | $284.00 Million | 0.56x | 4.04x |
Competitor Companies of BIOT by Market Capitalization
Companies near Biotage AB in the global market cap rankings as of March 18, 2026.
Key companies related to Biotage AB by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #99 globally with a market cap of $170.64 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #355 globally with a market cap of $61.46 Billion USD ( €59.87 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.52 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #99 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.64 Billion | $483.46 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #355 | EssilorLuxottica S. A. | PA:EL | $61.46 Billion | €203.90 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.52 Billion | $160.27 |
Biotage AB Historical Marketcap From 2015 to 2025
Between 2015 and today, Biotage AB's market cap moved from $154.48 Million to $ 1.02 Billion, with a yearly change of 24.88%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | Skr1.02 Billion | -10.95% |
| 2024 | Skr1.15 Billion | +21.45% |
| 2023 | Skr944.81 Million | -26.97% |
| 2022 | Skr1.29 Billion | -28.65% |
| 2021 | Skr1.81 Billion | +90.01% |
| 2020 | Skr954.31 Million | +12.10% |
| 2019 | Skr851.33 Million | +15.10% |
| 2018 | Skr739.66 Million | +31.80% |
| 2017 | Skr561.19 Million | +87.51% |
| 2016 | Skr299.28 Million | +93.73% |
| 2015 | Skr154.48 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Biotage AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.02 Billion USD |
| MoneyControl | $1.02 Billion USD |
| MarketWatch | $1.02 Billion USD |
| marketcap.company | $1.02 Billion USD |
| Reuters | $1.02 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.